AUSTIN (KXAN) — An Austin-based company was acquired by Colossal Biosciences, a biosciences company that has claimed to “de-extinct” animals, according to a Tuesday announcement. Viagen Pets and ...
Hosted on MSN
Colossal Biosciences Acquires Cloning Company Viagen: How It Advances De-Extinction and Conservation (Exclusive)
Colossal Biosciences has announced its first acquisition, bringing Viagen Pets and Equine, the world leader in animal cloning, into its growing biotechnology family. Viagen made headlines a few years ...
Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...
This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...
Colossal co-founder and CEO Ben Lamm (left) is interviewed by Bloomberg Texas bureau chief Julie Fine during a Venture Dallas session at the George W. Bush Presidential Center in University Park, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback